Skip to main content

Table 1 Basic characteristics of the enrolled patients

From: The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer

Variables

No. (%)

Age (years)

  ≤ 50

77 (53)

  > 50

68 (47)

Pathologic T stage

 1

50 (35)

 2–4

95 (65)

Pathologic N stage

 0

54 (37)

 1–3

91 (63)

Histologic grade

 1–2

92 (64)

 3

53 (36)

Lymphovascular invasion

 Absent

86 (59)

 Present

59 (41)

Type of surgery

 Breast conserving surgery

35 (24)

 Mastectomy

110 (76)

Estrogen receptor

 Negative

64 (44)

 Positive

81 (56)

Progesterone receptor

 Negative

87 (60)

 Positive

58 (40)

HER2

 Negative

108 (75)

 Positive

37 (25)

Chemotherapy

 Neoadjuvant

44 (30)

 Adjuvant

95 (66)

 No

6 (4)

Adjuvant radiotherapy

 No

81 (56)

 Yes

64 (44)

  1. HER2, human epidermal growth factor receptor 2